Logo image of VRME

VERIFYME INC (VRME) Stock Fundamental Analysis

NASDAQ:VRME - US92346X2062 - Common Stock

0.8902 USD
-0.02 (-2.67%)
Last: 8/29/2025, 8:00:02 PM
0.851 USD
-0.04 (-4.4%)
After Hours: 8/29/2025, 8:00:02 PM
Fundamental Rating

3

Overall VRME gets a fundamental rating of 3 out of 10. We evaluated VRME against 125 industry peers in the Electronic Equipment, Instruments & Components industry. The financial health of VRME is average, but there are quite some concerns on its profitability. VRME does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year VRME has reported negative net income.
VRME had a positive operating cash flow in the past year.
In the past 5 years VRME reported 4 times negative net income.
In multiple years VRME reported negative operating cash flow during the last 5 years.
VRME Yearly Net Income VS EBIT VS OCF VS FCFVRME Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

VRME's Return On Assets of -22.06% is on the low side compared to the rest of the industry. VRME is outperformed by 73.60% of its industry peers.
VRME's Return On Equity of -26.23% is on the low side compared to the rest of the industry. VRME is outperformed by 70.40% of its industry peers.
Industry RankSector Rank
ROA -22.06%
ROE -26.23%
ROIC N/A
ROA(3y)-36.52%
ROA(5y)-32.04%
ROE(3y)-56.82%
ROE(5y)-44.86%
ROIC(3y)N/A
ROIC(5y)N/A
VRME Yearly ROA, ROE, ROICVRME Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

VRME has a Gross Margin of 33.50%. This is comparable to the rest of the industry: VRME outperforms 52.80% of its industry peers.
VRME's Gross Margin has declined in the last couple of years.
VRME does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.64%
GM growth 5Y-15.56%
VRME Yearly Profit, Operating, Gross MarginsVRME Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

More info and screens

5

2. Health

2.1 Basic Checks

VRME does not have a ROIC to compare to the WACC, probably because it is not profitable.
VRME has more shares outstanding than it did 1 year ago.
VRME has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, VRME has a worse debt to assets ratio.
VRME Yearly Shares OutstandingVRME Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
VRME Yearly Total Debt VS Total AssetsVRME Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

VRME has an Altman-Z score of -3.30. This is a bad value and indicates that VRME is not financially healthy and even has some risk of bankruptcy.
VRME has a Altman-Z score of -3.30. This is amonst the worse of the industry: VRME underperforms 84.80% of its industry peers.
The Debt to FCF ratio of VRME is 3.62, which is a good value as it means it would take VRME, 3.62 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of VRME (3.62) is better than 68.00% of its industry peers.
A Debt/Equity ratio of 0.05 indicates that VRME is not too dependend on debt financing.
VRME has a Debt to Equity ratio (0.05) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 3.62
Altman-Z -3.3
ROIC/WACCN/A
WACC9.55%
VRME Yearly LT Debt VS Equity VS FCFVRME Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

2.3 Liquidity

VRME has a Current Ratio of 4.06. This indicates that VRME is financially healthy and has no problem in meeting its short term obligations.
VRME has a better Current ratio (4.06) than 77.60% of its industry peers.
A Quick Ratio of 4.04 indicates that VRME has no problem at all paying its short term obligations.
VRME has a Quick ratio of 4.04. This is amongst the best in the industry. VRME outperforms 83.20% of its industry peers.
Industry RankSector Rank
Current Ratio 4.06
Quick Ratio 4.04
VRME Yearly Current Assets VS Current LiabilitesVRME Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for VRME have decreased strongly by -105.88% in the last year.
The Revenue for VRME has decreased by -13.19% in the past year. This is quite bad
The Revenue has been growing by 151.62% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-105.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)-13.19%
Revenue growth 3Y203.02%
Revenue growth 5Y151.62%
Sales Q2Q%-15.55%

3.2 Future

VRME is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.94% yearly.
The Revenue is expected to decrease by -1.36% on average over the next years.
EPS Next Y53.25%
EPS Next 2Y23.79%
EPS Next 3Y14.94%
EPS Next 5YN/A
Revenue Next Year-15.51%
Revenue Next 2Y-5.37%
Revenue Next 3Y-1.36%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
VRME Yearly Revenue VS EstimatesVRME Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M 20M 25M
VRME Yearly EPS VS EstimatesVRME Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VRME. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VRME. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VRME Price Earnings VS Forward Price EarningsVRME Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

VRME's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 52.98
EV/EBITDA N/A
VRME Per share dataVRME EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

VRME's earnings are expected to grow with 14.94% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.79%
EPS Next 3Y14.94%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for VRME!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VERIFYME INC

NASDAQ:VRME (8/29/2025, 8:00:02 PM)

After market: 0.851 -0.04 (-4.4%)

0.8902

-0.02 (-2.67%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-13 2025-08-13/bmo
Earnings (Next)11-10 2025-11-10
Inst Owners18.96%
Inst Owner Change-43.35%
Ins Owners21.75%
Ins Owner Change2.54%
Market Cap10.97M
Analysts85
Price Target1.53 (71.87%)
Short Float %14.7%
Short Ratio0.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)51.91%
Min EPS beat(2)29.97%
Max EPS beat(2)73.86%
EPS beat(4)2
Avg EPS beat(4)-12.75%
Min EPS beat(4)-114.75%
Max EPS beat(4)73.86%
EPS beat(8)6
Avg EPS beat(8)22.6%
EPS beat(12)9
Avg EPS beat(12)25.11%
EPS beat(16)11
Avg EPS beat(16)-0.03%
Revenue beat(2)1
Avg Revenue beat(2)-3.6%
Min Revenue beat(2)-14.21%
Max Revenue beat(2)7.01%
Revenue beat(4)2
Avg Revenue beat(4)-3.48%
Min Revenue beat(4)-14.21%
Max Revenue beat(4)7.01%
Revenue beat(8)2
Avg Revenue beat(8)-3.32%
Revenue beat(12)4
Avg Revenue beat(12)-2.26%
Revenue beat(16)6
Avg Revenue beat(16)1.9%
PT rev (1m)9.09%
PT rev (3m)-7.69%
EPS NQ rev (1m)35.71%
EPS NQ rev (3m)35.71%
EPS NY rev (1m)23.26%
EPS NY rev (3m)15.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-18.38%
Revenue NY rev (1m)3.21%
Revenue NY rev (3m)3.21%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.5
P/FCF 52.98
P/OCF 12.68
P/B 0.76
P/tB 2.07
EV/EBITDA N/A
EPS(TTM)-0.35
EYN/A
EPS(NY)-0.17
Fwd EYN/A
FCF(TTM)0.02
FCFY1.89%
OCF(TTM)0.07
OCFY7.89%
SpS1.79
BVpS1.17
TBVpS0.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -22.06%
ROE -26.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.5%
FCFM 0.94%
ROA(3y)-36.52%
ROA(5y)-32.04%
ROE(3y)-56.82%
ROE(5y)-44.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.64%
GM growth 5Y-15.56%
F-Score4
Asset Turnover1.29
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 3.62
Debt/EBITDA N/A
Cap/Depr 55.53%
Cap/Sales 2.98%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.06
Quick Ratio 4.04
Altman-Z -3.3
F-Score4
WACC9.55%
ROIC/WACCN/A
Cap/Depr(3y)49.02%
Cap/Depr(5y)92.75%
Cap/Sales(3y)2.21%
Cap/Sales(5y)13.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-105.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y53.25%
EPS Next 2Y23.79%
EPS Next 3Y14.94%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.19%
Revenue growth 3Y203.02%
Revenue growth 5Y151.62%
Sales Q2Q%-15.55%
Revenue Next Year-15.51%
Revenue Next 2Y-5.37%
Revenue Next 3Y-1.36%
Revenue Next 5YN/A
EBIT growth 1Y7.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year113.16%
EBIT Next 3Y31.69%
EBIT Next 5YN/A
FCF growth 1Y119.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y327.63%
OCF growth 3YN/A
OCF growth 5YN/A